HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julie Teruya-Feldstein Selected Research

Hyperplasia

10/2011Synchronous follicular lymphoma, kaposi sarcoma, and castleman's disease in a HIV-negative patient with EBV and HHV-8 coinfection.
5/2002In situ localization of follicular lymphoma: description and analysis by laser capture microdissection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Julie Teruya-Feldstein Research Topics

Disease

64Neoplasms (Cancer)
01/2022 - 02/2002
22Lymphoma (Lymphomas)
01/2020 - 09/2002
11Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2019 - 03/2003
9B-Cell Lymphoma (Lymphoma, B Cell)
05/2013 - 03/2003
8Carcinogenesis
09/2014 - 01/2005
7Neoplasm Metastasis (Metastasis)
01/2018 - 04/2006
7Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2015 - 02/2002
7Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
06/2014 - 05/2002
6Leukemia
04/2015 - 11/2010
6Hodgkin Disease (Hodgkin's Disease)
02/2014 - 09/2004
4Breast Neoplasms (Breast Cancer)
10/2012 - 03/2010
3Multiple Myeloma
12/2021 - 09/2003
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2018 - 04/2010
3Immunoglobulin Light-chain Amyloidosis
01/2008 - 05/2006
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2022 - 02/2014
2Pancytopenia
07/2019 - 05/2004
2Primary Myelofibrosis (Myelosclerosis)
01/2018 - 03/2015
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2015 - 10/2014
2Splenomegaly
03/2015 - 07/2009
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
10/2013 - 05/2004
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
09/2013 - 07/2006
2T-Cell Lymphoma (Lymphoma, T Cell)
09/2013 - 10/2009
2Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
09/2013 - 07/2006
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2013 - 10/2009
2Melanoma (Melanoma, Malignant)
02/2013 - 03/2005
2Burkitt Lymphoma (Burkitt's Lymphoma)
12/2012 - 09/2003
2Carcinoma (Carcinomatosis)
02/2012 - 04/2006
2Hyperplasia
10/2011 - 05/2002
2Hypoxia (Hypoxemia)
03/2011 - 08/2006
2Lung Neoplasms (Lung Cancer)
03/2010 - 07/2006
2Adenocarcinoma of Lung
03/2010 - 10/2009
2Prostatic Neoplasms (Prostate Cancer)
08/2009 - 09/2008
2Amyloidosis
10/2007 - 05/2006
2Colorectal Neoplasms (Colorectal Cancer)
04/2006 - 10/2005
2Plasmacytoma
09/2003 - 07/2003
1Movement Disorders (Movement Disorder)
12/2021
1Parkinsonian Disorders (Parkinsonism)
12/2021
1Snoring
07/2021
1Airway Obstruction (Choking)
07/2021
1Pharyngitis (Sore Throat)
07/2021
1Dyspnea (Shortness of Breath)
07/2021
1Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders)
01/2021
1Intestinal Failure
01/2021
1Fibrosis (Cirrhosis)
01/2020

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
10/2016 - 05/2002
8Rituximab (Mabthera)FDA Link
01/2020 - 09/2002
7Phosphotransferases (Kinase)IBA
11/2015 - 07/2006
7MicroRNAs (MicroRNA)IBA
02/2014 - 10/2007
6Pharmaceutical PreparationsIBA
01/2018 - 10/2005
5AntibodiesIBA
07/2019 - 11/2004
5Transcription Factors (Transcription Factor)IBA
01/2016 - 10/2007
5Monoclonal AntibodiesIBA
08/2012 - 02/2002
5TOR Serine-Threonine KinasesIBA
03/2009 - 08/2005
4Biomarkers (Surrogate Marker)IBA
07/2012 - 08/2006
4Methotrexate (Mexate)FDA LinkGeneric
02/2006 - 09/2003
3Janus Kinase InhibitorsIBA
01/2020 - 03/2015
3CytokinesIBA
01/2018 - 10/2011
3Oncogene Proteins (Oncogene Protein)IBA
09/2014 - 08/2005
3Anaplastic Lymphoma KinaseIBA
09/2013 - 07/2006
3AntigensIBA
02/2013 - 10/2002
3Bortezomib (Velcade)FDA Link
07/2012 - 05/2006
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2010 - 09/2003
3Doxorubicin (Adriamycin)FDA LinkGeneric
04/2010 - 09/2003
3Biological ProductsIBA
12/2009 - 03/2004
3ErbB Receptors (EGF Receptor)IBA
03/2009 - 10/2005
2RNA Splicing FactorsIBA
01/2022 - 01/2018
2RNA (Ribonucleic Acid)IBA
01/2022 - 10/2012
2Chimeric Antigen ReceptorsIBA
12/2021 - 10/2016
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2019 - 06/2014
2EnzymesIBA
01/2018 - 07/2012
2LipidsIBA
01/2018 - 06/2014
2ruxolitinibIBA
11/2015 - 03/2015
2Protein Isoforms (Isoforms)IBA
09/2014 - 02/2002
2Cadherins (E-Cadherin)IBA
02/2014 - 03/2010
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
04/2013 - 08/2007
2NucleophosminIBA
04/2010 - 04/2008
2Messenger RNA (mRNA)IBA
03/2010 - 03/2010
2EverolimusFDA Link
03/2009 - 09/2008
2Sirolimus (Rapamycin)FDA Link
09/2008 - 08/2008
2Mechanistic Target of Rapamycin Complex 1IBA
09/2008 - 08/2008
2Eukaryotic Initiation Factor-4EIBA
08/2008 - 12/2007
2Melphalan (Alkeran)FDA LinkGeneric
01/2008 - 10/2007
2Dexamethasone (Maxidex)FDA LinkGeneric
10/2007 - 01/2006
2Thalidomide (Thalomid)FDA Link
10/2007 - 01/2006
2trans-sodium crocetinate (crocetin)IBA
08/2007 - 08/2005
2Proteasome InhibitorsIBA
08/2006 - 05/2006
2Drug CombinationsIBA
05/2006 - 01/2006
2Cytarabine (Cytosar-U)FDA LinkGeneric
02/2006 - 09/2003
1bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
12/2021
1idecabtagene vicleucelIBA
12/2021
1B-Cell Maturation AntigenIBA
12/2021
1Epithelial Cell Adhesion MoleculeIBA
01/2021

Therapy/Procedure

29Therapeutics
12/2021 - 09/2002
10Drug Therapy (Chemotherapy)
04/2015 - 09/2003
5Stem Cell Transplantation
01/2010 - 09/2002
2Transplantation
01/2020 - 10/2013
2Splenectomy
07/2009 - 05/2009
1Tracheostomy
07/2021
1Total Parenteral Nutrition
01/2021
1Immunotherapy
01/2020